Chinese Markets for Bladder Cancer Treatment

Table of Contents

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
• Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

• Bladder Cancer Treatment Drugs Industry Structure
• Market Size
• Market Growth Drivers
• Bladder Cancer Treatment Drugs Sales Volume
• Major Producer Facility Locations
• Major Producers' Sales Volume and Market Share
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investment
• Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

• Bladder Cancer Overview
• Bladder Cancer Treatment Drugs Market Overview
• Bladder Cancer Treatment Drugs Market Overview by Classification
  • Intraluminal Perfusion Agents
• Unilateral Chemotherapy Drug
• First-line Chemotherapy Drug
  • Immunomodulator
• Other Drugs
  • Bladder Cancer Treatment Drugs Import and Export by Classification
    • Bladder Cancer Treatment Drugs Import
    • Bladder Cancer Treatment Drugs Export
• Market Overview by Drug' s Active Principle
• Market Overview by Producers
• Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

• Bladder Cancer Treatment Drugs Markets Outlook Overview
• Government Regulation
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

VI. MARKETING STRATEGIES

• China Market Entry Overview
• China' s Distribution System
• Bladder Cancer Treatment Drugs Distribution Channels
• Transportation and Freight Infrastructure
• Communications

• China' s Market Entry
• Export to China
• Indirect export
• Direct Export
• License and Contract Manufacture
• Assembling in China
• Contract Manufacturing
• Trade Permit
• Investment
• Equity Joint Venture
• Contractual Joint Venture
• Wholly Foreign-Owned Enterprise

VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

• Profiles of Bladder Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

• Economic Outlook Summary

II. BUSINESS ENVIRONMENT

• Key Economic Indicators
• Industrial Output
• Population and Labor Force Trends
• Foreign Investment and Loans
• Foreign Trade

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

• Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008
• Bladder Cancer Treatment Drugs Sales Volume
• Major Producer Facility Location
• Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share in 2008
• Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

• Bladder Cancer Treatment Drugs Import by Country in 2008
• Bladder Cancer Treatment Drugs Export by Country in 2008
• Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
• Bladder Cancer Treatment Drugs Import by Drugs Classification
• Bladder Cancer Treatment Drugs Export by Drugs Classification
• Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share in 2008
• Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share in 2008
• Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

• Consumer Spending Trends
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds
• Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

• Bladder Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

• China' s GDP and Growth Rate
• Industrial Output by Ownership
• China' s Imports and Exports

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

• Bladder Cancer Treatment Drugs Sales Volume
• Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
• Top 14 Bladder Cancer Treatment Drugs Market Share in 2008

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

• Bladder Cancer Treatment Drugs Sales Volume
• Bladder Cancer Treatment Drugs Import
• Bladder Cancer Treatment Drugs Import by Country in 2008
• Bladder Cancer Treatment Drugs Export
• Bladder Cancer Treatment Drugs Export by Country in 2008
• Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008
• Intraluminal Perfusion Agents Sales Volume and Market Share
• Unilateral Chemotherapy Drug Sales Volume and Market Share
• First-Line Chemotherapy Drug Sales Volume and Market Share
• Immunomodulator Sales Volume and Market Share
• Other Drugs Sales Volume and Market Share
• Bladder Cancer Treatment Drugs Import by Classification in 2008
• Unilateral Chemotherapy Drug Import and Market Share
• First-Line Chemotherapy Drug Import and Market Share
• Intraluminal Perfusion Agents Import and Market Share
• Immunomodulator Import and Market Share
• Other Drugs Import and Market Share
• Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008
• Unilateral Chemotherapy Drug Export and Market Share
• First-Line Chemotherapy Drug Export and Market Share
• Intraluminal Perfusion Agents Export and Market Share
• Immunomodulator Export and Market Share

VI. MARKETING STRATEGIES

• China' s Dist